Newsletter | April 7, 2026

04.07.26 -- Rethinking ATMP Assurance When Sterility Timelines, Reality Misalign

SPONSOR

Turbocharge CAR-T Manufacturing: Industrializing Cell Therapy with Perfusion

As allogeneic CAR-T therapies scale, manufacturing intensification becomes essential for speed and cost efficiency. This Repligen webinar explores how XCell® ATF perfusion technology enables rapid, high-density CAR-T expansion in stirred-tank bioreactors while maintaining critical quality attributes. Learn how optimized perfusion, predictive scale-down modeling, and automated harvest integration support consistent production, improved yields, and scalable, economically viable CAR-T manufacturing. Click here to learn more.

FOCUS ON MANUFACTURING

Rethinking ATMP Assurance When Sterility Timelines, Reality Misalign

The 14-day sterility window creates patient risks and logistical delays. Evaluate the challenges of adopting rapid alternatives to align safety protocols with modern manufacturing timelines.

Advanced Technology Platform For Stem Cell-Derived Exosomes

Demand for EVs is rising due to their therapeutic promise. Explore two scalable platforms that address production challenges to support EVs' expanding clinical and commercial applications.

Rethink Capital Efficiency In Cell Processing

In cell processing, rigid, single-function equipment can lead to inefficiencies, wasted space, and scheduling conflicts. A versatile approach can help teams do more with less.

How To Identify Optimal Materials For Biopharma Single-Use Solutions

Have you thought about how the materials chosen for the tubing, transfer sets, single-use bags, and manifolds in therapy manufacturing could enhance your processes?

Revolutionizing Cell Therapy Manufacturing With AI

Discover how AI can optimize processes, improve efficiency, and enhance the understanding of cellular processes, ultimately leading to more effective and personalized patient treatments.

UF Devices Offer Higher-Throughput Options For Cloning And PCR Workflows

Learn how ultrafiltration devices in various steps of the cloning workflow can provide a more streamlined process compared to traditional methods of subcloning PCR-generated fragments.

Why Your Bioanalysis Bottleneck Is Costing You More Than You Think

Understand why turnaround time is a strategic variable, where speed is truly achievable, and how automation reshapes the path from sample submission to decision‑ready data.

Optimizing rAAV Production Using An In-House Suspension HEK293 Cell Line

Boost rAAV yields and quality while reducing costs with our proprietary HEK293 cell line and scalable, optimized manufacturing platform for gene therapy.

Next-Generation Cell Therapy: Eliminating Thermal Shock In Electroporation

Conventional electroporation methods struggle with damaging heat buildup. Gain insight into how innovative flow technology leverages physics to protect cells and enable large-scale therapeutic production.

The New Economics Of Cell Therapy Manufacturing

Cell therapy’s future hinges not just on scientific progress but on scalable manufacturing. Review why reliability and productivity now shape viability and how modernizing operations can support growth.

Connection Technologies Enable Modular Single-Use Systems

Single-use systems are increasingly prevalent in biotechnology processes. Compare the benefits, challenges, and solutions presented by modular single-use systems.

MANUFACTURING SOLUTIONS

HEK293 Perfusion Strategy For Enhanced AAV And LV Production - FUJIFILM Biosciences

Blast Freezer For Pharmaceuticals - Single Use Support

Prepare For Successful Biomarker Profiling From Cell-Free DNA - QIAGEN

Cell Nutrition That Delivers Healthy T Cells - Thermo Fisher Scientific

Connect With Cell & Gene: